A detailed history of Wells Fargo & Company transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Wells Fargo & Company holds 43,376 shares of TNDM stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,376
Previous 46,995 7.7%
Holding current value
$1.75 Million
Previous $1.66 Million 4.99%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$30.43 - $53.43 $110,126 - $193,363
-3,619 Reduced 7.7%
43,376 $1.75 Million
Q1 2024

May 10, 2024

BUY
$22.09 - $35.41 $253,173 - $405,834
11,461 Added 32.25%
46,995 $1.66 Million
Q4 2023

Feb 09, 2024

SELL
$14.28 - $31.03 $310,590 - $674,902
-21,750 Reduced 37.97%
35,534 $1.05 Million
Q3 2023

Nov 13, 2023

SELL
$19.33 - $36.22 $263,061 - $492,917
-13,609 Reduced 19.2%
57,284 $1.19 Million
Q2 2023

Aug 15, 2023

BUY
$24.18 - $42.46 $394,061 - $691,970
16,297 Added 29.85%
70,893 $1.74 Million
Q1 2023

May 12, 2023

BUY
$35.86 - $46.5 $197,911 - $256,633
5,519 Added 11.25%
54,596 $2.22 Million
Q4 2022

Feb 13, 2023

SELL
$35.49 - $56.15 $211,236 - $334,204
-5,952 Reduced 10.82%
49,077 $2.21 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $51,374 - $80,970
1,174 Added 2.18%
55,029 $2.63 Million
Q2 2022

Aug 12, 2022

SELL
$53.22 - $123.09 $957,853 - $2.22 Million
-17,998 Reduced 25.05%
53,855 $3.19 Million
Q1 2022

May 16, 2022

SELL
$101.89 - $150.09 $1.64 Million - $2.42 Million
-16,114 Reduced 18.32%
71,853 $8.36 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $10.4 Million - $13.5 Million
-87,926 Reduced 49.99%
87,967 $13.2 Million
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $87,431 - $120,989
935 Added 0.53%
175,893 $21 Million
Q2 2021

Aug 16, 2021

SELL
$77.0 - $100.19 $4.45 Million - $5.79 Million
-57,829 Reduced 24.84%
174,958 $17 Million
Q1 2021

May 13, 2021

SELL
$81.28 - $104.34 $2.49 Million - $3.2 Million
-30,650 Reduced 11.63%
232,787 $20.5 Million
Q4 2020

Feb 09, 2021

SELL
$86.4 - $121.75 $406,944 - $573,442
-4,710 Reduced 1.76%
263,437 $25.2 Million
Q3 2020

Nov 05, 2020

BUY
$95.43 - $116.09 $4.42 Million - $5.38 Million
46,312 Added 20.88%
268,147 $30.4 Million
Q2 2020

Aug 13, 2020

SELL
$60.05 - $98.92 $3.39 Million - $5.59 Million
-56,504 Reduced 20.3%
221,835 $21.9 Million
Q1 2020

May 14, 2020

BUY
$47.37 - $90.04 $13.2 Million - $25.1 Million
278,339 New
278,339 $17.9 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.6B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.